WEAVER GREGORY L

CIK 00012517799 companiesGAITHERSBURG, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001251779

Recent Transactions

50 trades

Purchase
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2026-03-06$3.54/sh+5,000→ 28,078 total
Award
Altimmune, Inc.$ALT
Stock Options (option to buy)
2026-02-26+259,000→ 259,000 total
Award
Altimmune, Inc.$ALT
Restricted Stock Units
2026-02-26+111,000→ 111,000 total
Exercise/Conversion
Altimmune, Inc.$ALT
Restricted Stock Units
2025-11-11−18,750→ 56,250 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2025-11-11+18,750→ 28,750 total
Tax Payment
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2025-11-11$4.28/sh−5,672→ 23,078 total
Award
Altimmune, Inc.$ALT
Stock Options (option to buy)
2025-10-01+166,800→ 166,800 total
Award
Altimmune, Inc.$ALT
Restricted Stock Units
2025-10-01+57,900→ 57,900 total
Purchase
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2025-03-13$5.20/sh+10,000→ 10,000 total
Award
Altimmune, Inc.$ALT
Restricted Stock Units
2024-11-11+75,000→ 75,000 total
Award
Altimmune, Inc.$ALT
Stock Options (option to buy)
2024-11-11+225,000→ 225,000 total
Sale
ATOSSA THERAPEUTICS, INC.$ATOS
Common Stock
2023-11-15$0.65/sh−50,000→ 55 total
Purchase
ATOSSA THERAPEUTICS, INC.$ATOS
Common Stock
2023-06-20$0.97/sh+50,000→ 50,055 total
Award
ATOSSA THERAPEUTICS, INC.$ATOS
Stock Option (right to buy)
2023-06-01+2,600,000→ 2,600,000 total
Award
ATOSSA THERAPEUTICS, INC.$ATOS
Stock Option (right to buy)
2023-05-04+125,000→ 125,000 total
Award
ATOSSA THERAPEUTICS, INC.$ATOS
Stock Option (right to buy)
2022-05-13+50,000→ 50,000 total
Award
Atai Beckley N.V.$ATAI
Stock Option
2022-03-02+228,000→ 228,000 total
Sale
ATOSSA THERAPEUTICS, INC.$ATOS
Common Stock
2021-07-02$5.58/sh−107,497→ 0 total
Exercise/Conversion
ATOSSA THERAPEUTICS, INC.$ATOS
Common Stock
2021-07-02$5.64/sh+4,581→ 4,581 total
Exercise/Conversion
ATOSSA THERAPEUTICS, INC.$ATOS
Common Stock
2021-07-02$2.38/sh+45,000→ 49,581 total
Exercise/Conversion
ATOSSA THERAPEUTICS, INC.$ATOS
Common Stock
2021-07-02$2.52/sh+45,000→ 94,581 total
Exercise/Conversion
ATOSSA THERAPEUTICS, INC.$ATOS
Common Stock
2021-07-02$1.70/sh+70,000→ 164,581 total
Tax Payment
ATOSSA THERAPEUTICS, INC.$ATOS
Common Stock
2021-07-02$6.40/sh−57,084→ 107,497 total
Exercise/Conversion
ATOSSA THERAPEUTICS, INC.$ATOS
Stock Option (right to buy)
2021-07-02−4,581→ 0 total
Exercise/Conversion
ATOSSA THERAPEUTICS, INC.$ATOS
Stock Option (right to buy)
2021-07-02−45,000→ 0 total
Exercise/Conversion
ATOSSA THERAPEUTICS, INC.$ATOS
Stock Option (right to buy)
2021-07-02−45,000→ 0 total
Exercise/Conversion
ATOSSA THERAPEUTICS, INC.$ATOS
Stock Option (right to buy)
2021-07-02−70,000→ 0 total
Purchase
Atai Beckley N.V.$ATAI
Common Shares
2021-06-22$15.00/sh+4,666→ 4,666 total
Award
Atai Beckley N.V.$ATAI
Stock Option
2021-06-17+67,726→ 67,726 total
Award
ATOSSA THERAPEUTICS, INC.$ATOS
Stock Option (right to buy)
2021-05-14+50,000→ 50,000 total
Award
ATOSSA THERAPEUTICS, INC.$ATOS
Stock Option (right to buy)
2020-05-15+70,000→ 70,000 total
Exercise/Conversion
Eloxx Pharmaceuticals, Inc.
Restricted Stock Units
2020-03-15−3,750→ 0 total
Tax Payment
Eloxx Pharmaceuticals, Inc.
Common Stock
2020-03-15$2.85/sh−1,086→ 10,431 total
Exercise/Conversion
Eloxx Pharmaceuticals, Inc.
Common Stock
2020-03-15+3,750→ 11,517 total
Exercise/Conversion
Eloxx Pharmaceuticals, Inc.
Restricted Stock Units
2020-01-30−5,000→ 15,000 total
Tax Payment
Eloxx Pharmaceuticals, Inc.
Common Stock
2020-01-30$3.91/sh−1,733→ 7,767 total
Exercise/Conversion
Eloxx Pharmaceuticals, Inc.
Common Stock
2020-01-30+5,000→ 9,500 total
Exercise/Conversion
Eloxx Pharmaceuticals, Inc.
Common Stock
2020-01-30+5,000→ 9,500 total
Tax Payment
Eloxx Pharmaceuticals, Inc.
Common Stock
2020-01-30$3.91/sh−1,733→ 7,767 total
Exercise/Conversion
Eloxx Pharmaceuticals, Inc.
Restricted Stock Units
2020-01-30+5,000→ 15,000 total
Award
ATOSSA THERAPEUTICS, INC.$ATOS
Stock Option (right to buy)
2019-05-17+45,000→ 45,000 total
Disposition to Issuer
Zyla Life Sciences
Stock Option (Right to Buy)
2019-01-31−75,000→ 0 total
Disposition to Issuer
Zyla Life Sciences
Stock Option (Right to Buy)
2019-01-31−2,083→ 0 total
Disposition to Issuer
Zyla Life Sciences
Stock Option (Right to Buy)
2019-01-31−667→ 0 total
Disposition to Issuer
Zyla Life Sciences
Stock Option (Right to Buy)
2019-01-31−29,666→ 0 total
Disposition to Issuer
Zyla Life Sciences
Stock Option (Right to Buy)
2019-01-31−20,000→ 0 total
Disposition to Issuer
Zyla Life Sciences
Stock Option (Right to Buy)
2019-01-31−10,000→ 0 total
Disposition to Issuer
Zyla Life Sciences
Stock Option (Right to Buy)
2019-01-31−58,133→ 0 total
Award
Eloxx Pharmaceuticals, Inc.
Restricted Stock Units
2019-01-30+20,000→ 20,000 total
Award
Eloxx Pharmaceuticals, Inc.
Stock Options
2019-01-30+60,000→ 60,000 total

Companies

Recent Filings

Address

910 CLOPPER ROAD SUITE 201S

GAITHERSBURG, MD, 20878

View on SEC.gov